Verde Bio Holdings, Inc.
VBHI · OTC
1/31/2024 | 10/31/2023 | 7/31/2023 | 4/30/2023 | |
|---|---|---|---|---|
| Revenue | $76 | $59 | $76 | $132 |
| % Growth | 27.7% | -21.4% | -42.4% | – |
| Cost of Goods Sold | $62 | $55 | $72 | $84 |
| Gross Profit | $14 | $5 | $4 | $47 |
| % Margin | 17.8% | 8.1% | 5.5% | 36% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $418 | $308 | $331 | $34 |
| SG&A Expenses | $418 | $308 | $331 | $34 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $6 | $0 | $0 | $384 |
| Operating Expenses | $424 | $308 | $331 | $449 |
| Operating Income | -$410 | -$303 | -$327 | -$402 |
| % Margin | -540.2% | -509.8% | -431.9% | -305.7% |
| Other Income/Exp. Net | -$1,083 | -$29 | $10 | -$38 |
| Pre-Tax Income | -$1,493 | -$332 | -$317 | -$440 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,493 | -$332 | -$317 | -$440 |
| % Margin | -1,964.8% | -557.9% | -418.5% | -334.8% |
| EPS | -0.001 | -0 | -0 | -0 |
| % Growth | -300% | 0% | 33.3% | – |
| EPS Diluted | -0.001 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 1,856,602 | 1,725,338 | 1,611,555 | 1,506,065 |
| Weighted Avg Shares Out Dil | 1,856,602 | 1,725,338 | 1,611,555 | 1,506,065 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $26 |
| Interest Expense | $0 | $11 | $1 | $26 |
| Depreciation & Amortization | $62 | $60 | $86 | $98 |
| EBITDA | -$348 | -$261 | -$255 | -$316 |
| % Margin | -458% | -439.2% | -337.4% | -240.2% |